Feb 7, 2026

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics: 

• Introduction (0:00)
• Neoadjuvant Treatment for Localized Colorectal Cancer (CRC) — Dr Seligmann (2:39)
• Emerging Novel Approaches to Adjuvant Treatment for Localized CRC —...

Feb 6, 2026

Featuring perspectives from Dr Hanny Al-Samkari, Dr Cindy Neunert and Prof Francesco Zaja, including the following topics: 

• Introduction (0:00)
• Case: A woman in her early 30s with chronic relapsing immune thrombocytopenia (ITP) receives eltrombopag with ongoing stabilization of platelet counts — Neil Morganstein, MD...

Feb 5, 2026

Featuring an interview with Dr Terence Friedlander, including the following topics:

• Final analysis of the Phase III, open-label, randomized POTOMAC trial (0:00)
• KEYNOTE-905 trial: Perioperative enfortumab vedotin with pembrolizumab for muscle-invasive bladder cancer (MIBC) (5:25)
• The neoadjuvant gemcitabine...

Feb 3, 2026

Featuring an interview with Dr Sagar Lonial, including the following topics:

• KLN-1010: A novel, in vivo gene therapy generating anti-BCMA chimeric antigen receptor T cells (0:00)
• Phase III DREAMM-7 and DREAMM-8 studies of belantamab mafodotin-based combination therapy for patients with relapsed/refractory (R/R)...

Feb 2, 2026

Featuring perspectives from Dr Jaffer A Ajani, Dr Samuel J Klempner, Dr Rutika Mehta and Dr John Strickler, moderated by Dr Klempner, including the following topics: 

• Introduction (0:00)
• HER2-Targeted Approaches for Advanced Gastroesophageal Cancers — Dr Ajani (2:02)
• Faculty Panel Discussion: Cases and Questions from...